| Global Health Limited (GLH) ORDINARY FULLY PAID |
Health Care |
$5 |
GLH 4C September 25 QTR Cash Flow Report
|
28 Oct 2025 9:04AM |
$0.100 |
$0.088 |
fallen by
12%
|
|
GLH - Price-sensitive ASX Announcement
Full Release
Key Points
- Receipts from customers: $2,362,000
- Net cash outflow from operations: $1,065,000
- End of quarter cash balance: $439,000
- Delayed R&D refund affecting cash flow
- No significant investing activities
- Net inflow from financing activities: $137,000
- Payments to related parties: $91,000
- AI leverage for operational efficiency
- Future financial strategies and obligations
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$101 |
Update - Notification of buy-back - CAM
|
28 Oct 2025 9:04AM |
$0.680 |
$0.695 |
risen by
2.21%
|
|
| Resouro Strategic Metals Inc (RAU) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$11 |
Becoming a substantial holder
|
28 Oct 2025 9:04AM |
$0.265 |
$0.230 |
fallen by
13.21%
|
|
| Alvo Minerals Limited (ALV) ORDINARY FULLY PAID |
Materials |
$22 |
Zinc-Copper Potential Confirmed at Touro Prospect, Palma
|
28 Oct 2025 9:03AM |
$0.028 |
$0.090 |
risen by
221.43%
|
|
ALV - Price-sensitive ASX Announcement
Full Release
Key Points
- Newly discovered Touro Prospect at Palma Cu-Zn Project confirmed for zinc-copper potential.
- Auger drilling and FLEM surveys at Touro reveal consistent Zn, Cu, and Pb anomalies.
- Alvo holds a district scale landholding over 1,000 km² with multiple prospects.
- Palma hosts a JORC 2012 Mineral Resource Estimate of 7.6Mt @ 2% CuEq.
- Touro is positioned as the highest priority drill target for Alvo.
- Touro's mineralised trend extends for over 1km with high-grade gossan occurrences.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sunshine Metals Limited (SHN) ORDINARY FULLY PAID |
Materials |
$46 |
Quarterly Activities Report
|
28 Oct 2025 9:03AM |
$0.024 |
$0.018 |
fallen by
25%
|
|
SHN - Price-sensitive ASX Announcement
Full Release
Key Points
- Diamond drilling commenced at Sybil with multiple epithermal veins intersected.
- High-grade gold results were reported at Francis Creek.
- Liontown studies are advancing with resource updates and mining studies.
- $5 million placement to fund drilling and studies.
- Board restructuring to focus on Queensland operations.
- Cash reserves at the end of the quarter were approximately $5.1 million.
- The strategic shift to a Queensland-based Board with new appointments.
- Fieldwork at Francis Creek confirmed classic epithermal textures.
- The company's resource inventory includes Greater Liontown VMS and Plateau Resources.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WT Financial Group Limited (WTL) ORDINARY FULLY PAID |
Financials |
$46 |
Notice of Annual General Meeting/Proxy Form
|
28 Oct 2025 9:03AM |
$0.160 |
$0.135 |
fallen by
15.63%
|
|
| Resouro Strategic Metals Inc (RAU) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$11 |
Resouro Engages Market Maker Services
|
28 Oct 2025 9:02AM |
$0.265 |
$0.230 |
fallen by
13.21%
|
|
RAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Resouro Strategic Metals Inc. engages Independent Trading Group INC. to provide market-making services.
- The engagement is subject to regulatory approval and complies with TSX Venture Exchange policies.
- Independent Trading Group INC. will receive a $7,000 monthly fee for their services.
- The agreement is initially for one month and automatically renews unless terminated with 30 days’ notice.
- The market-making services aim to enhance market depth and contribute to liquidity by entering orders on both sides of the book.
- Resouro is a mineral exploration and development company focused on projects in Brazil, namely the Tiros Titanium-Rare Earths Project and the Novo Mundo Gold Project.
- The Tiros project comprises 28 mineral concessions with significant resource estimates in titanium dioxide and rare earths oxides.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$15 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Oct 2025 9:00AM |
$0.069 |
$0.077 |
risen by
11.59%
|
|
OD6 - Price-sensitive ASX Announcement
Full Release
Key Points
- OD6 Metals Limited ended the quarter with A$3.045 million in cash.
- Operating cash flow was negative A$133,000 due to exploration and administrative costs.
- A$2.5 million was raised to support project developments.
- The Splinter Rock Rare Earth Project received significant focus with ongoing testwork and drilling.
- Gulf Creek Copper Project drilling targeted unexplored prospects.
- Innovative process flowsheets are being developed for better project economics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$25 |
Quarterly Activities Report /Appendix 4C Cash Flow Statement
|
28 Oct 2025 9:00AM |
$0.010 |
$0.015 |
risen by
50%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- Executed licensing agreement with Sakar Healthcare Ltd for oncology generics in Australia and New Zealand.
- Signed a binding term sheet with Cadila Pharmaceuticals Ltd for launching generics in cardiovascular and metabolic markets.
- Appointed Mr David Gulland as Chief Operating Officer.
- Advanced AlgoraeOS Version 2.0 for AI drug discovery with multi-GPU architecture.
- Conducted lab-in-the-loop validation with Peter MacCallum Cancer Centre.
- Progressed pre-clinical development of AI-116 for Dementia and AI-168 for Cardiovascular.
- Net operating cash outflow for the quarter was approximately $394,957.
- Cash reserves at the end of the quarter were $1.92 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tarrina Resources Limited (TR8) ORDINARY FULLY PAID |
Consumer Staple |
$8 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Oct 2025 8:58AM |
$0.004 |
$0.023 |
risen by
475%
|
|
TR8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of divestment of My Foodie Box meal kit business.
- Binding share purchase agreement with MondoRox Pty Ltd for the acquisition of Rox 1 Pty Ltd and Rox 2 Pty Ltd.
- Prospectus lodged with ASIC to raise $5 million through a public offer.
- Shareholder approvals obtained for acquisition and public offer.
- Raised $734K during the quarter, including $500,000 from Promissory Notes.
- Net cash used in operating activities was $363K.
- Cash equivalents at the end of the period were $348K.
- Estimated quarters of funding available is less than one.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Conneqt Health Limited (CQT) ORDINARY FULLY PAID |
Health Care |
$30 |
New US Clinical Trial Contract
|
28 Oct 2025 8:58AM |
$0.034 |
$0.053 |
risen by
55.88%
|
|
CQT - Price-sensitive ASX Announcement
Full Release
Key Points
- Awarded Phase 2b clinical trial contract with a U.S.-based company.
- Focus on therapies for hypertension and cardiovascular diseases.
- Trial commences in Q4 2025 across 30 U.S. sites.
- Contract valued at approximately A$1.1 million.
- Provision of SphygmoCor® XCEL and Oscar 2 ABPM systems.
- Includes setup, training, and data management services.
- Highlights Conneqt's precision and scalability in cardiovascular studies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,846 |
Update - Notification of buy-back - AFI
|
28 Oct 2025 8:57AM |
$7.380 |
$7.060 |
fallen by
4.34%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$313 |
Update - Notification of buy-back - AMH
|
28 Oct 2025 8:56AM |
$1.090 |
$0.990 |
fallen by
9.17%
|
|
| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$54 |
Update - Notification of buy-back - EPY
|
28 Oct 2025 8:56AM |
$0.210 |
$0.205 |
fallen by
2.38%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$16,849 |
Application for quotation of securities - COH
|
28 Oct 2025 8:56AM |
$288.600 |
$257.630 |
fallen by
10.73%
|
|
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$134 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Oct 2025 8:55AM |
$0.340 |
$0.320 |
fallen by
5.88%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Partnership with Genentech including USD $5.5 million upfront payment.
- Agreement with Radiopharm Theranostics with potential up to AUD $89 million.
- $3.7 million R&D tax incentive refund received.
- Cash balance of $14.3 million at 30 September 2025.
- Focus on DEP® platform and strategic partnerships.
- Progression of DEP® HER2 radiopharmaceuticals program towards clinical trials.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| New Frontier Minerals Limited (NFM) ORDINARY FULLY PAID |
Materials |
$29 |
Quarterly Cashflow Report - September 2025
|
28 Oct 2025 8:55AM |
$0.020 |
$0.017 |
fallen by
15%
|
|
NFM - Price-sensitive ASX Announcement
Full Release
Key Points
- New Frontier Minerals Limited's quarterly cash flow report for September 2025.
- Operating cash flow reported a net outflow of $376,000.
- Payments for exploration and evaluation were $214,000.
- Ending cash balance was $1,406,000.
- Payments to related parties totaled $551,000.
- Report complies with ASX Listing Rules and Australian Accounting Standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tesoro Gold Ltd (TSO) ORDINARY FULLY PAID |
Materials |
$233 |
Quarterly Cashflow Report
|
28 Oct 2025 8:55AM |
$0.062 |
$1.310 |
risen by
2,012.90%
|
|
TSO - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities amounted to $652,000 for the current quarter.
- Investing activities resulted in a cash outflow of $3,217,000 primarily due to exploration and evaluation expenses.
- Financing activities saw a net cash outflow of $264,000.
- The company ended the quarter with $3,747,000 in cash and cash equivalents.
- Tesoro Gold Ltd has planned fundraising activities to support the El Zorro Project.
- The company has received commitments to raise $34 million, with $26.7 million already received.
- Tesoro Gold Ltd expects to continue its operations and meet business objectives due to recent fundraising.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lefroy Exploration Limited (LEX) ORDINARY FULLY PAID |
Materials |
$67 |
September 2025 Quarterly Cashflow Report - Amended
|
28 Oct 2025 8:54AM |
$0.165 |
$0.270 |
risen by
63.64%
|
|
| Far East Gold Ltd (FEG) ORDINARY FULLY PAID |
Materials |
$57 |
New Gold Discovery at North Bermol
|
28 Oct 2025 8:54AM |
$0.135 |
$0.155 |
risen by
14.81%
|
|
FEG - Price-sensitive ASX Announcement
Full Release
Key Points
- New high-grade gold discovery at North Bermol, Papua Province, Indonesia.
- Drilling reveals a northwest-trending shear zone with significant gold mineralisation.
- Notable drill intersections include 2.6m at 3.9 g/t Au and 5m at 4.9 g/t Au.
- Discovery confirms district-scale potential of the Idenburg project.
- Pending assays from additional drill holes to further test high-grade gold sources.
- Strategic importance in expanding gold footprint and identifying new structural targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kingston Resources Limited (KSN) ORDINARY FULLY PAID |
Materials |
$105 |
2025 Notice of AGM, Proxy Form and Letter of Access
|
28 Oct 2025 8:53AM |
$0.130 |
$0.125 |
fallen by
3.85%
|
|
| Heavy Rare Earths Limited (HRE) ORDINARY FULLY PAID |
Materials |
$8 |
Acquisition of Prospect Hill Tin Project, All Mineral Rights
|
28 Oct 2025 8:53AM |
$0.050 |
$0.039 |
fallen by
22%
|
|
HRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of the Prospect Hill Tin Project by HRE
- HRE now holds all mineral rights, expanding beyond uranium
- Located in the Curnamona Craton, South Australia
- South Ridge prospect identified as highly prospective
- Rich geological data set available from past operators
- Plan to fast-track mineral resource estimation at South Ridge
- Project enhances HRE's strategic position in critical minerals
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clearview Wealth Limited (CVW) ORDINARY FULLY PAID |
Financials |
$342 |
Update - Notification of buy-back - CVW
|
28 Oct 2025 8:53AM |
$0.595 |
$0.545 |
fallen by
8.40%
|
|
| Solis Minerals Ltd (SLM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$11 |
Additional Cucho Exploration Concessions
|
28 Oct 2025 8:53AM |
$0.051 |
$0.044 |
fallen by
13.73%
|
|
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,475 |
Update - Notification of buy-back - WHC
|
28 Oct 2025 8:52AM |
$7.130 |
$7.820 |
risen by
9.68%
|
|
Call 1300 880 160
Start a chat
Schedule a call
